United States· US:0071-0525_5d3eee75-8d10-4969-b883-81b1d5d3ae97
Celontin
A medicinal product containing methsuximide, registered in United States by Parke-Davis Div of Pfizer Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- METHSUXIMIDE
- Manufacturer
- Parke-Davis Div of Pfizer Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc110071052524100 CAPSULE in 1 BOTTLE (0071-0525-24)
- ndc110071-0525-24
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methsuximide in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCelontin 300mg KapsealsWarner-Pd
- SwitzerlandPetinutin, KapselnPfizer AG
- GermanyPetinutinPfizer Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · Petinutin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/52bf06a4-bb35-40b7-9154-c84ee13f2581 GET /v1/drugs/52bf06a4-bb35-40b7-9154-c84ee13f2581?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "300",
"substance": "METHSUXIMIDE",
"productndc": "0071-0525",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA010596",
"marketing_category": "NDA"
}See everything about methsuximide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.